Cadrenal Therapeutics News

Cadrenal Therapeutics | 8-K: Current report

Apr 9 09:30 ET

Cadrenal Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Apr 2 12:58 ET

Cadrenal Therapeutics | 8-K: Current report

Mar 12 12:54 ET

Cadrenal Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 12 08:42 ET

Cadrenal Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Mar 12 08:07 ET

Cadrenal Therapeutics | 8-K: Current report

Mar 11 09:16 ET

Cadrenal Therapeutics | 8-K: Current report

Mar 5 17:31 ET

Cadrenal Therapeutics | 8-K/A: Current report (Amendment)

Feb 15 08:07 ET

Cadrenal Therapeutics | 8-K: Current report

Feb 12 16:53 ET

Cadrenal Therapeutics | 8-K: Current report

Nov 9, 2023 09:15 ET

Cadrenal Therapeutics | 8-K: Current report

Oct 23, 2023 17:04 ET

Cadrenal Therapeutics | 8-K: Current report

Sep 8, 2023 16:10 ET

Cadrenal Therapeutics | DEFA14A: Others

Aug 31, 2023 16:05 ET

Cadrenal Therapeutics | DEFA14A: Others

Aug 31, 2023 16:05 ET

Cadrenal Therapeutics | DEF 14A: Definitive information statements

Aug 28, 2023 16:55 ET

Cadrenal Therapeutics | 8-K: Current report

Aug 18, 2023 06:06 ET

Cadrenal Therapeutics | 8-K: Current report

Aug 16, 2023 16:10 ET

Cadrenal Therapeutics | 8-K: Current report

Aug 10, 2023 09:16 ET

Cadrenal Therapeutics | 8-K: Current report

Jul 24, 2023 09:20 ET

Cadrenal Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Jul 24, 2023 09:15 ET